Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

01:14 EDT 23rd October 2014 | BioPortfolio

Respiratory News - Page: 2Twitter RSS

Read the latest Respiratory News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Respiratory.

Search or Follow Our Respiratory - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Respiratory - Page: 2 News.
You can also follow our Respiratory - Page: 2 news stories on Twitter: @Respiratory_Bio

Showing "respiratory airways lungs breath" News Articles 26 to 50 of 3,000+

Tuesday 21st October 2014

WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test

ANAHEIM, Calif., Oct. 21, 2014 /PRNewswire/ -- Influenza will affect as many as 200,000 people this year and with flu-associated deaths in the United States as high as 49,000 people.  The main way that influenza viruses are thought to spread is from person to person in respiratory droplets of coughs and sneezes. Ebola has a serve way of death, but kills much fewer people each year than the...

Synairgen PLC's potential is Astra-nomical

Recent share price weakness offers an attractive entry point for respiratory disease specialist Synairgen (LON:SNG), reckons broker N+1 Singer. The broker has initiated coverage of the pharmaceutical company with a ‘buy’ recommendation an...

The Discovery House Hosts Comedy Night with Mark Lundholm

Alcohol and drug addiction treatment center clients and staff benefit from a night of laughter and fun LOS ANGELES, CA (PRWEB) October 21, 2014 The Discovery House recently held a comedy night for its residential clients and staff. The event was held Sunday, September 21, 2014, at the Discovery Transitions Meeting Hall, in Van Nuys, California. The night was full of lighthearted laughter and fun,...

Sorin Group Partners with Respicardia, Inc., a Developer of Innovative Implantable Therapies Designed to Improve Respiratory and Cardiovascular Health

Investment will fund on-going clinical testing of the remedē® System for patients with central sleep apnea, a significant co-morbidity in heart failure. Commercial launch of the product by Sorin in selected European countries to start beginning 2015 Sorin Group (MIL:SRN) (Reuters Code: SORN.MI), a global medical device company and a leader in the tre...

CyberKnife Treatment Helps Metastatic Breast Cancer Patient

RENO, Nev., Oct. 21, 2014 /PRNewswire/ -- As the second-most diagnosed cancer in women in the U.S., breast cancer impacts the lives of many. Debbie Black, a Nevada resident, is among those whose life has been dramatically impacted by the disease. Initially diagnosed with stage II breast cancer at the age of 30, Black underwent aggressive chemotherapy and hormonal treatment. She was cancer-...

Inogen Announces Release To Market Of The At Home, An Innovative Home Oxygen Concentrator

GOLETA, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the...

ResMed Inc. Enhances U-Sleep Patient Management Platform With Action View For Easier Management By Exception

SAN DIEGO, Oct. 21, 2014 /PRNewswire/ --ResMed (NYSE:RMD) today announced a significant improvement to U-Sleep, its premium patient management platform, which allows home medical equipment providers (HMEs) to quickly and effectively manage patients with sleep apnea and respiratory conditions. U-Sleep's new Action...

Exalenz Bioscience Launches Pivotal Study of World’s First Breath-Based Test to Diagnose Clinically Significant Portal Hypertension

Portal hypertension is the most common complication of cirrhosis, accounting for significant morbidity and mortality Multinational study to be conducted in Europe and the U.S. Exalenz Bioscience (TASE:EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver dis...

Smokers' homes 'as polluted as Beijing'

"Living with smoker 'as bad as living in polluted city'," BBC News reports. Scottish researchers have estimated that the level of fine particulate matter (PM2.5) in smokers' households is similar to those found in a heavily polluted city such as Beijing. PM2.5 are tiny particles less than two and a half microns wide that are components of air pollution. Because of their size, they are ab...

Dramatic decline in mortality rates for acute respiratory distress syndrome

The largest study to date of mortality trends in patients with acute respiratory distress syndrome shows that the rate of mortality dropped significantly over a 16-year period. Advances in critical care medicine are seen as a direct cause of the decl...

Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express

WORCESTER, Mass. and TORONTO, Oct. 21, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that its wholly owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), has issued a white paper outlining the advantages of its Ii-Key technology in the development of an effective Ebola vaccine. Antigen Express has a proprietary technology ...

Philips unveils "The Answer" at Medtrade Fall 2014, offering end-to-end solutions to homecare providers in the new era of healthcare

ATLANTA, Oct. 21, 2014 /PRNewswire/ -- Philips Respironics, a division of Royal Philips (NYSE: PHG, AEX: PHIA), will showcase "The ANSWER," a comprehensive business transformation process that connects product, technology and workflow innovations for both sleep and respiratory care management, at Medtrade Fall in Atlanta from October 20 – 23, 2014. At a time when challenges in the sle...

ResMed Enhances U-Sleep Patient Management Platform With Action View For Easier Management By Exception

SAN DIEGO, Oct. 21, 2014 /PRNewswire/ --ResMed (NYSE:RMD) today announced a significant improvement to U-Sleep, its premium patient management platform, which allows home medical equipment providers (HMEs) to quickly and effectively manage patients with sleep apnea and respiratory conditions. U-Sleep's new Action View feature gives HMEs a fast method of sorting patients into actionable groups R...

CDC Awards the National Blood Clot Alliance Funding to Expand Public Awareness about Blood Clots

ROCKVILLE, Md., Oct. 21, 2014 /PRNewswire/ -- The National Blood Clot Alliance today announced that it has been awarded funding from the Centers for Disease Control and Prevention (CDC) to implement an education and awareness program aimed at improving public recognition about deadly blood clots that affect up to 900,000 Americans each year. Logo - http://photos.prnewswire.com/prnh/20141020/...

Viagra Outside The Bedroom - It Also Helps Protect The Heart

Brett Smith for redOrbit.com - Your Universe Online The drug known as Viagra was originally being investigated as a cardiac medication and when study participants began to report an unintended side effect – the course of studying the phosphodiesterase type 5 inhibitor (PDE5i) shifted completely. Now, a new report from a team of Italian scientists published in the journal BMC Medicine has found...

Monday 20th October 2014

Immunovaccine Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 10/21/14 -- Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE: IMV), a clinical stage vaccine and immunotherapy company, today announced positive results from anthrax challenge studies in non-human primates (monkeys) using an anthrax vaccine formulated with Immunovaccine's DepoVax™ delivery system. The studies, performed by the National Institute of Alle...

Large-Scale Study Shows Dramatic Decline in Mortality Rates for ARDS

AUSTIN, TX--(Marketwired - October 21, 2014) - The largest study to date of mortality trends in patients with acute respiratory distress syndrome (ARDS) shows that the rate of mortality dropped significantly over a 16-year period. Advances in critical care medicine are seen as a direct cause of the decline. The study abstract was released today in an online supplement of the of the journal CHEST a...

Blood Biomarker May Detect Lung Cancer, Study Presented at CHEST 2014

AUSTIN, TX--(Marketwired - October 21, 2014) - A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract was released today in an online supplement of the journal CHEST and will be presented at CHEST 2014, the annual meeting of the Amer...

Zenosense, Inc.; Protocol Design -- Lung Cancer Detection Tests

VALENCIA, SPAIN -- (Marketwired) -- 10/21/14 -- Zenosense, Inc. (OTCQB: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on developing and marketing devices to detect the MRSA "Super-Bug" and to detect signs of lung cancer in exhaled breath, is pleased to announce the completion of protocol design of a significant lung cancer detection trial to be carried out...

Quidel Reports Third Quarter 2014 Financial Results

SAN DIEGO, CA -- (Marketwired) -- 10/21/14 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2014. Third Quarter and Recent 2014 Highlights: Third Quarter 2014 Results Total revenues for the third quarter of 2014 rose...

Pulmonary Hypertension Association Prepares for Pulmonary Hypertension Awareness Month this November

The Pulmonary Hypertension Association has designated November as Pulmonary Hypertension Awareness Month. Pulmonary hypertension is a rare-debilitating disease of the lungs that affects the functioning of the heart and can lead to right heart failure. Without treatment, the average survival rate is 2.8 years. Silver Spring, Md. (PRWEB) October 20, 2014 The Pulmonary Hypertension Association (PHA)...

UT Arlington researcher's device could detect vapors in environment or a person's breath

(University of Texas at Arlington) A University of Texas at Arlington researcher has received a three-year, $400,369 National Science Foundation grant to build a handheld device that could analyze a person's breath to reveal whether certain dangerous...

U.S. calls pathogen research timeout

The White House Office of Science and Technology Policy (OSTP) and HHS announced the U.S. government has halted funding for "gain of function" (GOF) research that could increase the pathogenicity or respiratory transmission of influenza, SARS and ME...

Exposure to traffic pollution during pregnancy can damage future child's lungs

Women who are exposed to traffic pollution while pregnant are increasing the chances of damaging the lungs of their unborn children, concludes a study published online in the journal Thorax.

Global LVAD (Left Ventricular Assist Devices) Market Size, Share, Growth, Trends and Forecast Report 2014 Edition: MarketResearchReports.Biz

MarketResearchReports.Biz include new market research report"Global LVAD Market Report 2014 Edition" to its huge collection of research reports.Browse All Devices Market Research Reports at http://www.marketresearchreports.biz/tag/Devices Albany, NY (PRWEB) October 20, 2014 LVAD, Left Ventricular Assist Device, is a mechanical device that circulates blood throughout the body when the he...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks